E-drug: Ellen t'Hoen on developments leading to Doha
-------------------------------------------------------------------------
[Copied from Ip-Health. KM]
't Hoen E. TRIPS, Pharmaceutical Patents, and Access to Essential Medicines:
A Long
Way From Seattle to Doha. Chicago J Int Law 2002; 3(1): 27-48.
Full article:
http://www.accessmed-msf.org/upload/PressClips/24620021440503/Chicagolawjour
nalTRIPS.pdf
[NB long URL. Please repair]
-------------------
Abstract:
http://cjil.uchicago.edu/contents/v3n1/thoen.html
The AIDS crisis draws attention to the fact that millions in the
developing world lack access to medicines. In many cases prohibitive
drug prices, often a result of intellectual property protection throw up
a barrier to needed treatments.
The WTO TRIPS Agreement which sets out the minimum standards for the
protection of intellectual property, has come under fierce criticism
because of the anticipated negative effects on the availability of
affordable medicines.
The 4th WTO Ministerial Conference held in 2001 in Doha, Qatar, adopted
the Declaration on TRIPS and Public Health. The Declaration gives
primacy to public health over private intellectual property and
clarifies WTO Members' rights to use the TRIPS safeguards. This paper
describes the developments that led to the adoption of this Declaration.
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html